BRC Therapeutics participates in regulators' workshop advancing botanical drug development

Ascletis reports positive results from ASC50 clinical study for treatment of plaque psoriasis

REGENXBIO reports positive three-year durability data for surabgene lomparvovec in diabetic retinopathy

XtalPi submits US FDA IND application for KQTD-126 in chronic intestinal pain

AbbVie secures EU approval for RINVOQ in polyarticular juvenile idiopathic arthritis

Altesa BioSciences presents positive vapendavir clinical data at ERS International Congress 2026

Kali Therapeutics' KT501 Investigational New Drug application cleared by US FDA

Teva reports positive Phase 2a data for TEV '408 in celiac disease

AbbVie seeks EMA approval for subcutaneous induction of risankizumab in Crohn's disease

AstraZeneca and Amgen report Tezspire met primary endpoints in Phase III EoE trial

Oxcia receives EMA orphan designation for OXC-201 in idiopathic pulmonary fibrosis

Graviton BioScience reports positive trial results for GV101 in chronic Graft versus Host Disease

Cellenkos' CK0803 granted US FDA Fast Track designation for ALS

European Commission grants orphan designation for Vanda's imsidolimab

CureGene commences dosing in Phase I trial of CG-0416